Breast imaging: Mammography and ultrasonography

Magnetic Resonance Imaging Clinics of North America

Volumn 9, Issue 2, 2001, Pages 251-271

  Bassett, L W ^a   Kim, C H ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAMMOGRAPHY; REVIEW;

ADULT; BIOPSY, NEEDLE; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; ULTRASONOGRAPHY, MAMMARY;

EID: 0034868143     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. 14 Years of follow-up from the Edinburgh randomized trial of breast-cancer screening
2. Standards for the performance of screening mammography
3. Standards for the performance of diagnostic mammography and problem-solving breast evaluation
4. Stereotactic core-needle biopsy of the breast
5. Mammographic analysis of calcifications
6. Atypical ductal hyperplasia: Histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-G stereotactically guided directional vacuum-assisted biopsy
7. Acceptability of periodic follow-up as an alternative to biopsy for mammographically detected lesions interpreted as probably benign
8. Screening mammography in community practice: Positive predictive value of abnormal findings and yield of follow-up diagnostic procedures
9. Value of routine examination of breast cyst fluids
10. Analysis of clinically occult and mammographically occult breast tumors
11. Breast masses: Mammographic and sonographic evaluation
12. Fibroadenoma of the breast: Sonographic appearance
13. Significance of margination of benign and malignant infiltrative mammary lesions: Roentgenologic-pathologic correlation
14. Nonpalpable breast lesions: Recommendations for biopsy based on suspicion of carcinoma at mammography
15. Realtime breast sonography: Application in 300 consecutive patients
16. Interval carcinomas in the Malmö screening trial
17. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative rates and histologic underestimation rates after long-term follow up
18. Stereotactic fine-needle aspiration biopsy for nonpalpable breast lesions
19. Diagnostic importance of radiographic density of noncalcified breast masses: Analysis of 91 lesions
20. Follow up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: Frequency of mammographic change and false negative rate
21. Percutaneous large-core biopsy of papillary breast lesions
22. Lobular carcinoma in situ at percutaneous breast biopsy: Surgical biopsy findings
23. Mammography medical audit: Primer for the mammography quality standards act (MQSA)
24. Delayed diagnosis of breast cancer as a result of normal mammograms
25. The American College of Radiology mammography accreditation program
26. 16-Year mortality from breast cancer in the UK trial of early detection of breast cancer
27. Breast cancer screening for women 40-49, January 21-23, 1997
28. Stereotactic breast biopsy with a biopsy gun
29. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-G vacuum suction probe vs. 14-G automatic gun
30. Benign versus malignant solid breast masses: US differentiation
31. Appropriate role of core breast biopsy in the management of probably benign lesions
32. Mammographic features of 300 consecutive nonpalpable breast cancers
33. Nonpalpable, circumscribed, noncalcified solid breast masses: Likelihood of malignancy based on lesion size and age of patient
34. Mammographic features of "early" breast cancer
35. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials
36. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions
37. Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare